These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19233284)

  • 1. Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli.
    Zinzula L; Esposito F; Mühlberger E; Trunschke M; Conrad D; Piano D; Tramontano E
    Protein Expr Purif; 2009 Jul; 66(1):113-9. PubMed ID: 19233284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein.
    Ramaswamy VK; Di Palma F; Vargiu AV; Corona A; Piano D; Ruggerone P; Zinzula L; Tramontano E
    Virus Res; 2018 Mar; 247():61-70. PubMed ID: 29427597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.
    Zinzula L; Esposito F; Pala D; Tramontano E
    Antiviral Res; 2012 Mar; 93(3):354-63. PubMed ID: 22289166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Myricetin as an Ebola Virus VP35-Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay.
    Daino GL; Frau A; Sanna C; Rigano D; Distinto S; Madau V; Esposito F; Fanunza E; Bianco G; Taglialatela-Scafati O; Zinzula L; Maccioni E; Corona A; Tramontano E
    Biochemistry; 2018 Nov; 57(44):6367-6378. PubMed ID: 30298725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
    Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
    Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.
    Hartman AL; Bird BH; Towner JS; Antoniadou ZA; Zaki SR; Nichol ST
    J Virol; 2008 Mar; 82(6):2699-704. PubMed ID: 18199658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the Ebola virus GP(1,2) protein and its fragments in E. coli.
    Das D; Jacobs F; Feldmann H; Jones SM; Suresh MR
    Protein Expr Purif; 2007 Jul; 54(1):117-25. PubMed ID: 17383893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
    Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
    J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of RNA aptamers targeting Ebola virus VP35.
    Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
    Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
    Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
    PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
    Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.
    Shabman RS; Leung DW; Johnson J; Glennon N; Gulcicek EE; Stone KL; Leung L; Hensley L; Amarasinghe GK; Basler CF
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S911-8. PubMed ID: 21987769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.
    Boehmann Y; Enterlein S; Randolf A; Mühlberger E
    Virology; 2005 Feb; 332(1):406-17. PubMed ID: 15661171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of antigenic determinant profiles of the Ebola virus VP35 protein N-terminal region using its short recombinant fragments].
    Rudzevich TN; Ternovoĭ VA; Kazachinskaia EI; Razumov IA; Chepurnov AA; Loktev VB; Netesov SV
    Mol Gen Mikrobiol Virusol; 2003; (2):38-40, backcover. PubMed ID: 12800775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
    Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
    Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
    Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.